Brittany Bagley

COO & CFO Brittany Bagley sells 5,969 shares of AXON at $485.00; stock -45.6% from 52-week high, her prior 5 AXON trades were all well-timed at 90-day mark.

Brittany Bagley, COO & CFO, sold 5,969 shares of AXON ENTERPRISE, INC. at $485.00 on 2026-06-02, reducing her holdings by 5,969 shares from 83,053 to 77,084 shares. The stock currently trades at $481.48, down 45.6% from its 52-week high of $885.92. Notably, her prior 5 trades at AXON all registered negative 90-day returns (ranging from -23.9% to -23.0%), establishing a pattern where she sold before subsequent declines. Her cross-ticker track record shows a 90d well-timed rate of 80.00% across 20 prior sells. The company's fundamentals remain strong—annual revenue growth of +33.5% and net income of $169,312,000.00—yet the valuation reflects elevated expectations with a P/E of 188.08.

COO & CFO Brittany Bagley sells 4,266 shares at blended $552.90 for $2.358M; stock up 19.8% in 30d, down 33.5% from 52-week high.

Bagley executed 6 separate sales totaling 4,266 shares for $2,358,679.64 on 2026-03-02 at prices ranging from $550.28 to $556.62, reducing her holdings from 103,501 to 99,235 shares. The sale occurred after a 19.8% 30-day run-up and near recovery from a 33.5% discount to the 52-week high of $870.97. Her prior 4 measurable sales at AXON were all well-timed at the 90-day mark, with negative 90-day returns following each trade, establishing a pattern of selling ahead of declines. The blended transaction price of $552.90 sits 4.7% below current price of $579.09, suggesting modest opportunity cost, but her timing history at this ticker provides material context: insiders with demonstrated ability to execute sales before stock weakness warrant elevated monitoring, particularly when fundamentals show negative net income ($-2.2M last quarter) despite strong top-line growth (+33.5% annual revenue growth) and an elevated P/E of 9651.50.

AXON COO & CFO Bagley sells 2,000 shares at $580.00 for $1.2M; stock down 35.2% from 52-week high, P/E 173.09.

Brittany Bagley, serving as COO & CFO, sold 2,000 shares at $580.00 on 2025-12-11, reducing holdings by 1.9% to 103,501 shares. The stock is currently trading at $564.28, down 35.2% from its 52-week high of $870.97 and down 25.4% over the past 90 days, suggesting significant momentum deterioration post-trade. Across Bagley's broader open-market transaction history, her prior sells have generated an average 90-day return of +30.9% with a 8.33% well-timed rate, but at the same ticker AXON, none of the measurable prior sells showed well-timed outcomes at the 90-day mark. The company's latest quarter shows net income of $-2.2M despite revenue of $710.6M and annual revenue growth of +33.2%, revealing a profitability pressure that contrasts sharply with the lofty P/E of 173.09 and $44.5B market cap. This sale by the CFO occurs against a backdrop of recent stock weakness and operating loss, warranting assessment of whether the fundamentals have deteriorated or whether liquidity management is driving the transaction.

COO & CFO Bagley sells 2,500 AXON shares at $610.00; stock down 36.0% from 52-week high, 91.1K shares held post-sale

Brittany Bagley, COO & CFO of Axon Enterprise, sold 2,500 shares at $610.00 on 2025-11-10 for $1,525,000.00, reducing her holdings by 2.7% to 91,092 shares. The stock has since declined significantly, trading at $557.29, approximately 36.0% below its 52-week high of $870.97 and down 20.9% in the 30 days following the sale. Bagley's same-ticker transaction history at AXON shows five prior sales all occurring on 2025-09-29, each with measurable 30-day gains (+6.0% to +6.9%), but no 90-day outcomes yet available to establish a timing pattern at this ticker. Her cross-ticker track record spans 20 prior sells with an average 90-day return of +33.2% and a 90-day well-timed rate of 7.69%, indicating her sales historically have not preceded declines. The CFO's continued accumulation of a 91.1K-share position despite ongoing sales, combined with the stock's recent sharp decline from elevated valuations (P/E 170.95), presents a mixed signal: sales by senior management warrant attention, particularly given the company's latest quarter net income was $-2.2M despite $710.6M in revenue and 33.2% annual growth.

AXON CFO Bagley sold 5,000 shares across 6 transactions for $3.6M on 2025-09-29; retains 93.6K shares.

Brittany Bagley, COO & CFO of Axon Enterprise, executed 6 separate sales totaling 5,000 shares for $3,569,388.47 on 2025-09-29, reducing her post-transaction holdings to 93,592 shares. The blended average price of $713.88 sits above the current price of $717.64, a modest $3.76 premium. Her prior AXON-specific trade history shows mixed timing outcomes: 1 of 4 measurable prior sells at this ticker resulted in a negative 90-day return. The stock is currently -17.6% from its 52-week high and down 4.0% over 30 days, trading at a substantial P/E of 172.10. The sale represents a 5.1% reduction in her pre-transaction holdings, a material but not decisive reduction in her stake.

Axon COO & CFO Bagley sells 870 shares at $773.25; retains 113.0K shares amid elevated valuation (P/E 182.44).

Bagley Brittany, COO & CFO of Axon Enterprise, sold 870 shares at $773.25 on 2025-09-15 for total value $672.7K, reducing holdings by 0.8% to 113.0K shares. The sale occurred as the stock trades at $760.79, down 12.6% from its 52-week high of $870.97. Axon's fundamentals show strong growth with annual revenue growth of 33.2% and a market cap of $59.7B, but valuation is stretched with a P/E of 182.44. Examining Bagley's 5 prior sales at Axon, only 1 of 5 achieved negative 90-day returns (well-timed); the majority saw post-sale stock appreciation, and his cross-ticker track record shows an average 90-day return of +30.9% after sales across 20 trades, indicating sells have historically been poorly timed. The current sale carries limited signal value given the small position reduction and the historical pattern of this insider selling ahead of rallies rather than declines.

AXON CFO & COO Bagley sells 3,400 shares at $700.00 for $2,380,000; retains 131,833 shares post-sale

Brittany Bagley, COO & CFO, sold 3,400 shares of AXON at $700.00 on 2025-05-13 for $2,380,000.00, reducing her holdings by 2.5% to 131,833 shares. The sale occurred near AXON's 52-week high of $728.53, with the stock up 26.7% over the preceding 30 days and 9.6% over 90 days. Across her prior AXON trades, only 1 of 5 prior sells showed positive 90-day returns (well-timed selling), suggesting limited predictive pattern at this ticker. Her broader cross-ticker track record shows sells have averaged 31.6% positive 90-day returns historically, though with a well-timed rate of only 5.26%, indicating her sell timing has generally not preceded declines. The modest sale size relative to her substantial remaining position indicates no material shift in commitment to the company.

COO & CFO Brittany Bagley sells 3,500 shares of AXON at $640.00 (Nov 22); stock +39.2% in 30 days, +70.3% in 90 days off lows

Brittany Bagley, the company's COO & CFO, sold 3,500 shares at $640.00 on 2024-11-22 for $2,240,000.00, reducing her holdings from 80,135 to 76,635 shares. This sale occurs within a sharply appreciating stock environment: AXON has gained 39.2% over 30 days and 70.3% over 90 days, trading near its 52-week high of $636.95 (the sale price of $640.00 is just above that mark). The timing of a C-suite executive's sale during a steep rally merits investor attention, particularly given that Bagley's cross-ticker track record shows her 18 prior sales averaged 41.0% positive 90-day returns (sales that were followed by further gains), indicating her sells have historically been poorly-timed. At the same ticker, she executed four other sales on 2024-11-15 immediately preceding this transaction, establishing a pattern of repeated selling in the same period, though outcomes are not yet measurable.

COO & CFO Bagley Brittany sold 6,325 shares for $3,787,070.29 in 5 transactions on 2024-11-15

Brittany Bagley, COO & CFO of Axon Enterprise, executed 5 separate sales totaling 6,325 shares for $3,787,070.29 on 2024-11-15, reducing her holdings by -7.3% from 86,460 shares to 80,135 shares. The sales occurred across a narrow price band ($596.45–$600.88), just below the current price of $610.20 and only -1.0% from the 52-week high of $616.14. At Axon specifically, Bagley's prior 4 measurable sells posted 90-day returns of +63.8%, +61.0%, +60.5%, and +60.2%—all strongly positive—with zero well-timed exits at the 90-day mark, indicating her prior sales at this ticker were consistently followed by further stock appreciation. The cross-ticker track record shows her 13 prior sells averaged +41.0% over 90 days with a 0.00% well-timed rate, similarly reflecting a pattern of selling into strength rather than before declines. Against a P/E of 155.66 and annual revenue growth of +31.4%, this sale occurs at elevated valuation and pricing, with no indication of scheduled trading plan activity to explain the timing.

COO & CFO Brittany Bagley sold 4,338 shares of AXON at $378.95 on 2024-09-12, reducing holdings to 98,825 shares.

Brittany Bagley, COO & CFO of Axon Enterprise, sold 4,338 shares for $1,643,876.42 at $378.95 on 2024-09-12, reducing her holdings by 4.2% to 98,825 shares. The sale occurred near the 52-week high of $384.51, with the stock up 31.5% over 90 days and 4.2% over 30 days. However, her cross-ticker track record shows 12 prior sells with an average 90-day return of +21.2% and a 0.00% well-timed rate, indicating past sales have generally not preceded stock declines. At Axon specifically, she executed five sales on 2024-08-15 (timing outcomes not yet measurable), providing limited prior precedent for evaluating this transaction's strategic timing.